Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02457000 · ClinicalTrials.gov registry record
Sleep, Circadian Rhythm & Skin Health
A clinical trial of Healthy and Psoriasis, sponsored by University Hospitals Cleveland Medical Center.
- Completed
- Registry status
- 59
- Enrollment target
- 1
- Study location
NCT02457000: Completed study of Healthy and Psoriasis, sponsored by University Hospitals Cleveland Medical Center.
NCT02457000 is a study of Healthy and Psoriasis that has completed, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 59 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02457000, a study of Healthy and Psoriasis, has completed, sponsored by University Hospitals Cleveland Medical Center.
- COMPLETED
- Registry status
- 59 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to explore the mechanisms behind how sleep quality may affect skin aging, skin integrity and skin disease.
Primary Outcome
The volunteers may be asked to wear a wrist actigraph to measure movement. This watch would be worn for 24 hours per day for 7-14 days. The volunteer may also be asked to fill out questionnaires regarding their sleep patterns. Note: Other methods of assessing sleep patterns may also be used including a portable polysomnogram or a standard, overnight sleep study.
Study Locations (1)
Ohio
- University Hospitals Cleveland Medical Center - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2015-03 |
| Est. Completion | 2020-08 |
What the finished NCT02457000 record still lists
NCT02457000 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 59 participants, a relatively small participant target, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (91% lower).
The record links to 4 conditions, with Healthy appearing as the primary indexed condition, and to 0 interventions.
NCT02457000 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT02457000 about?
NCT02457000 is a clinical study titled "Sleep, Circadian Rhythm & Skin Health". The purpose of this study is to explore the mechanisms behind how sleep quality may affect skin aging, skin integrity and skin disease.
What is the current status of trial NCT02457000?
This trial is currently completed. The enrollment target is 59 participants. The study started on 2015-03. Estimated completion is 2020-08.
What conditions does trial NCT02457000 study?
This clinical trial studies the following conditions: Healthy, Psoriasis, Eczema, Acne.
Who is sponsoring clinical trial NCT02457000?
This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02457000 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02457000's enrollment target sits among peer trials
59 403rd of 1090 higher than 685 of 1,090 other Healthy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mapping Auricular Vagus Nerve Circuitry
RECRUITING · Early Phase 1
-
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
RECRUITING · Phase 1
-
A Study of LY3867070 in Healthy Participants
RECRUITING · Phase 1
-
The Modulatory Effect of Female Sex Hormones on Spinal Neuroplasticity
RECRUITING
-
Breathing & Blood Pressure
RECRUITING
-
Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03801083 · 59 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers
- NCT04332367 · 59 participants · Phase 2
Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance
- NCT05489575 · 59 participants · NA
CPAP for the Treatment of Supine Hypertension
- NCT06721689 · 59 participants · Phase 1
PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia